Impact of fungal infections on solid-organ transplant recipients

Clinical Microbiology Newsletter

Volumn 27, Issue 16, 2005, Pages 123-126

  Mizuta, Mari ^a,b   Blumberg, Emily A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ATOVAQUONE; CALCINEURIN INHIBITOR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; ECHINOCANDIN; IMMUNOSUPPRESSIVE AGENT; PENTAMIDINE; PYRROLE DERIVATIVE; RAPAMYCIN; TACROLIMUS; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CLINICAL FEATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC TEST; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FUNGAL STRAIN; GRAFT VERSUS HOST REACTION; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INJECTION SITE REACTION; MORBIDITY; MORTALITY; MYCOSIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; POSTOPERATIVE INFECTION; RISK ASSESSMENT; RISK FACTOR;

EID: 26944468989     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2005.08.001     Document Type: Article

References (12)

1. Paya C.V. Fungal infections in solid-organ transplantation Clin. Infect. Dis 16 1993 677 678
2. Kubak B.M. Fungal infections in lung transplantation Transpl. Infect. Dis 4 2002 S24 S31
3. American Society of Transplant Surgeons and American Society of Transplantation Fungal infections Am. J. Transplant 4 2004 S110 S134
4. Husain S. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi Clin. Infect. Dis 37 2003 221 229
5. Fishman J.A., Rubin R.H. Infection in organ-transplant recipients N. Engl. J. Med 338 1998 1741 1751
6. Rubin R.H. Overview: pathogenesis of fungal infections in the organ transplant recipient Transpl. Infect. Dis 4 2002 S12 S17
7. American Society of Transplant Surgeons and American Society of Transplantation Pneumocystis jiroveci (formerly Pneumocystis carinii) Am. J. Transplant 4 2004 S135 S141
8. C.F. Thomas Jr., Limper A.H. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin. Respir Infect 13 1998 289 295
9. Marr K.A. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance J. Infect. Dis 190 2004 641 649
10. Clark T.A., Hajjeh R.A. Recent trends in the epidemiology of invasive mycoses Curr. Opin. Infect. Dis 15 2002 569 574
11. Johnson L.B. Voriconazole: a new triazole antifungal agent Clin. Infect. Dis 36 2003 630 637
12. Singh N. Antifungal prophylaxis in solid-organ transplant recipients: consideration for clinical trial design Clin. Infect. Dis 39 2003 S200 S206